A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

This study was undertaken to determine the highly sensitive method for detecting tumour lymphatic vessels in all the fields of each slide (LV), lymphatic microvessel density (LMVD) and lymphatic vessel invasion (LVI) and to compare them with other prognostic parameters using immunohistochemical stai...

Bibliografski detalji
Glavni autori:	Kato, T, Prevo, R, Steers, G, Roberts, H, Leek, R, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Jackson, D, Harris, A, Gatter, K, Pezzella, F
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
od: Jackson, D, i dr.
Izdano: (2001)

Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.
od: Vainionpää, N, i dr.
Izdano: (2007)

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
od: Prevo, R, i dr.
Izdano: (2001)

The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy.
od: Pillai, G, i dr.
Izdano: (2003)

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
od: Johnson, L, i dr.
Izdano: (2007)

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
od: Gale, N, i dr.
Izdano: (2007)

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.
od: Kato, T, i dr.
Izdano: (2007)

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
od: Cursiefen, C, i dr.
Izdano: (2002)

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.
od: Jackson, D
Izdano: (2004)

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
od: Bono, P, i dr.
Izdano: (2004)

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor (LYVE-1) by ocular surface cells.
od: Chen, L, i dr.
Izdano: (2004)

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
od: Jackson, D
Izdano: (2003)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the Lymphatic Vessel Endothelial receptor LYVE-1
od: Stanly, TA, i dr.
Izdano: (2020)

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
od: Trojan, L, i dr.
Izdano: (2004)

Lymphatic and blood vessels in parathyroid tumors: Immunohistochemical study with LYVE-1 and von Willebrand factor
od: Tatsuo Tomita
Izdano: (2024-08-01)

Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization
od: Lawrance, W, i dr.
Izdano: (2016)

Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
od: Jackson, D
Izdano: (2018)

DOES PERITUMORAL LYVE-1 IMMUNOREACTIVITY PREDICT THE SENTINEL LYMPH NODE METASTASIS?
od: Hilal Koçdor, i dr.
Izdano: (2006-01-01)

High LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in breast cancer.
od: Bono, P, i dr.
Izdano: (2004)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
od: Koukourakis, M, i dr.
Izdano: (2005)

A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
od: Nightingale, T, i dr.
Izdano: (2009)

The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours
od: Edwards, J, i dr.
Izdano: (2003)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
od: Banerji, S, i dr.
Izdano: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
od: Banerji, S, i dr.
Izdano: (2016)

Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.
od: Tarik Attout, i dr.
Izdano: (2009-12-01)

Distribution of lymphatic vessels in normal and arthritic human synovial tissues.
od: Xu, H, i dr.
Izdano: (2003)

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
od: Banerji, S, i dr.
Izdano: (2010)

Novel erectile analyses revealed augmentable penile Lyve‐1, the lymphatic marker, expression
od: Kota Fujimoto, i dr.
Izdano: (2024-01-01)

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
od: Williams, C, i dr.
Izdano: (2003)

Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
od: Heinzelbecker, J, i dr.
Izdano: (2013)

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1
od: Johnson, L, i dr.
Izdano: (2017)

LYVE-1 expression in the endothelium of newly formed vessels of carotid atherosclerotic plaque
od: Anna N. Evdokimenko, i dr.
Izdano: (2020-09-01)

Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles
od: Guo Q, i dr.
Izdano: (2013-06-01)

MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis
od: Hoi Leong Xavier Wong, i dr.
Izdano: (2016-03-01)

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
od: Shikshya Shrestha, i dr.
Izdano: (2020-07-01)

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
od: Leek, R, i dr.
Izdano: (1994)

LYVE-1 and hyaluronan - a molecular velcro
od: Lawrance, W
Izdano: (2013)

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
od: Stacker, SA, i dr.
Izdano: (2001)

Pre-collecting lymphatic vessels form detours following obstruction of lymphatic flow and function as collecting lymphatic vessels.
od: Kimi Asano, i dr.
Izdano: (2020-01-01)

Deciphering the heterogeneity of the Lyve1+ perivascular macrophages in the mouse brain
od: C. Siret, i dr.
Izdano: (2022-11-01)